Mr. Mark D. Michael is an Independent Director of Natus Medical Incorporated. Mr. Michael is a private investor, director, and consultant. He has served as the Senior Executive Advisor to Control Risks Group since March 2007. From October 2003 until March 2007, Mr. Michael acted as a private investor and consultant. Mr. Michael was Senior Vice President Legal, General Counsel, and Secretary of 3Com Corporationrationration from 1997 through September 2003
Michael served as a director of Nollenberger Capital Partners, Inc. from 2003, and Chairman of the board of directors from February 2010, until it was acquired in January 2011. He holds a Bachelor of Arts degree in History from Stanford University and a Juris Doctorate from the University of California Los Angeles School of Law.
Management Efficency
The company has return on total asset (ROA) of 3.06 % which means that it generated profit of $3.06 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 1.47 % meaning that it created $1.47 on every $100 dollars invested by stockholders.
The company currently holds 32.86 M in liabilities with Debt to Equity (D/E) ratio of 0.12 which may suggest the company is not taking enough advantage from borrowing. Natus Medical Inc has Current Ratio of 1.68 which is within standard range for the sector.
Natus Medical Incorporated offer neurodiagnostic and newborn care solutions worldwide. Natus Medical Inc [BABY] is traded on NASDAQ in USA. It is located in San Carlos, CA and employs 1,028 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
Nasdaq Natus Medical Inc
0.86%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Berlin
